Lv5
1020 积分 2022-02-02 加入
Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study
1个月前
已完结
Real-world comparative outcomes of FOLFOX vs FOLFIRI as second-line therapy in metastatic biliary tract cancer
1个月前
已关闭
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
6个月前
已完结
Bicarbonate-integrated transarterial chemoembolization (TACE) in real-world hepatocellular carcinoma
8个月前
已完结
皖公网安备34019202002308
